Found: 15
Select item for more details and to access through your institution.
Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype.
- Published in:
- FASEB Journal, 2014, v. 28, n. 2, p. 693, doi. 10.1096/fj.12-225771
- By:
- Publication type:
- Article
Neuropilin‐1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
- Published in:
- FEBS Journal, 2022, v. 289, n. 1, p. 183, doi. 10.1111/febs.16119
- By:
- Publication type:
- Article
Phytochemicals as Immunomodulatory Agents in Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2657, doi. 10.3390/ijms24032657
- By:
- Publication type:
- Article
Melanoma and Vitiligo: In Good Company.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 22, p. 5731, doi. 10.3390/ijms20225731
- By:
- Publication type:
- Article
Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.
- Published in:
- Current Oncology, 2024, v. 31, n. 1, p. 588, doi. 10.3390/curroncol31010042
- By:
- Publication type:
- Article
3 Days for 3Rs 2023: Refinement, Reduction, Replacement.
- Published in:
- Altex, 2024, v. 41, n. 2, p. 329, doi. 10.14573/altex.2402121
- By:
- Publication type:
- Article
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2529, doi. 10.1007/s00432-021-03811-3
- By:
- Publication type:
- Article
Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.
- Published in:
- European Journal of Immunology, 2015, v. 45, n. 3, p. 922, doi. 10.1002/eji.201445052
- By:
- Publication type:
- Article
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma.
- Published in:
- Biomedicines, 2021, v. 9, n. 12, p. 1930, doi. 10.3390/biomedicines9121930
- By:
- Publication type:
- Article
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09373-9
- By:
- Publication type:
- Article
Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1346687
- By:
- Publication type:
- Article
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1197630
- By:
- Publication type:
- Article
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09373-9
- By:
- Publication type:
- Article
Safe-Shields: Basal and Anti-UV Protection of Human Keratinocytes by Redox-Active Cerium Oxide Nanoparticles Prevents UVB-Induced Mutagenesis.
- Published in:
- Antioxidants, 2023, v. 12, n. 3, p. 757, doi. 10.3390/antiox12030757
- By:
- Publication type:
- Article
Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1437325
- By:
- Publication type:
- Article